RECOMBINATE

This brand name is authorized in Estonia, Lithuania, Poland, South Africa

Active ingredients

The drug RECOMBINATE contains one active pharmaceutical ingredient (API):

1 Factor VIII (antihemophilic factor) UNII P89DR4NY54 - ANTIHEMOPHILIC FACTOR, HUMAN RECOMBINANT

Octocog alfa (Full length recombinant human coagulation factor VIII (rDNA)) is a purified protein that has 2,332 amino acids. It is produced by recombinant DNA technology in baby hamster kidney cells (BHK) into which the human factor VIII gene has been introduced. Read about Octocog alfa

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
B02BD02	Coagulation factor VIII	B Blood and blood forming organs → B02 Antihemorrhagics → B02B Vitamin K and other hemostatics → B02BD Blood coagulation factors
Discover more medicines within B02BD02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: EE	Ravimiamet	Identifier(s): 1007648, 1007671, 1007705, 1484883, 1484939, 1484940
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1067501, 1067502, 1067503, 1070020, 1070021, 1070022
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100150305, 100182370, 100182386, 100182400, 100298278, 100298284
Country: ZA	Health Products Regulatory Authority	Identifier(s): A39/30.3/0591, A39/30.3/0592, A39/30.3/0593